Evidence map›Paper›PMID 34770361›Full record

ArticleSensors (Basel, Switzerland)2021

Wearable Cardioverter-Defibrillator-Measured Step Count for the Surveillance of Physical Fitness during Cardiac Rehabilitation.

Boldizsar Kovacs, Flavia Müller, David Niederseer, Nazmi Krasniqi, Ardan M Saguner, Firat Duru, Matthias Hermann

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Boldizsar KovacsDepartment of Cardiology, University Heart Center Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-7972-5199
Flavia MüllerDepartment of Cardiology, University Heart Center Zurich, 8091 Zurich, Switzerland.
David NiederseerDepartment of Cardiology, University Heart Center Zurich, 8091 Zurich, Switzerland.ORCID 0000-0003-3089-1222
Nazmi KrasniqiGZO Regional Healthcare Center, 8620 Zurich, Switzerland.
Ardan M SagunerDepartment of Cardiology, University Heart Center Zurich, 8091 Zurich, Switzerland.
Firat DuruDepartment of Cardiology, University Heart Center Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-4748-0158
Matthias HermannDepartment of Cardiology, University Heart Center Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-0694-7719
Zurich Heart House · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe wearable cardioverter-defibrillator (WCD) has a built-in accelerometer, which allows tracking of patients' physical activity by remote monitoring. It is unclear whether WCD-measured physical activity, step count, and heart rate correlate with established tools for the assessment of cardiopulmonary fitness such as the 6-min walk test (6MWT).

objectiveTo correlate measurements of patient physical activity through the WCD with a supervised 6MWT during in-patient cardiac rehabilitation (CR) and to allow their use as surrogate parameters of cardiopulmonary fitness in an out-patient setting.

methodsConsecutive patients with a history of WCD use treated at our center and an in-patient CR following an index hospitalization were included. Baseline characteristics, measurements of WCD accelerometer (median daily step count, median daily activity level), median daily heart rate, and clinically supervised 6MWT at admission and discharge of CR were obtained.

resultsForty-one patients with a mean age of 55.5 (±11.5) years were included. Thirty-five patients (85.4%) were male and 28 patients (68%) had a primary prophylactic WCD-indication. The most common underlying heart diseases were ischemic heart disease (24 patients 58.6%) and dilated cardiomyopathy (13 patients, 31.7%). Median CR duration was 20 (IQR 19.75-26.25) days. 6MWT distance increased from a mean of 329 m (±107) to 470 m (±116) during CR (

conclusionsRemote monitoring of median daily step count as assessed by the WCD's accelerometer showed positive correlation with the 6MWT and could serve as a surrogate for cardiopulmonary exercise capacity. Assessment of daily step count and activity level measured remotely by the WCD could help to tailor optimal exercise instruction for patients not attending CR.

Indexed as

Cardiac RehabilitationDefibrillators, ImplantableWearable Electronic DevicesDeath, Sudden, CardiacHumansMaleMiddle AgedPhysical Fitnessaccelerometercardiac rehabilitationheart failurestep countwearable cardioverter–defibrillator

Identifiers

PMID34770361
PMCPMC8588232
OpenAlexW3210009596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.